Depletion of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) induced by phenylephrine or endothelin causes the inhibition of acetylcholine-activated K ؉ current (I KACh ) in atrial myocytes. In the present study, we have investigated the hypothesis that muscarinic receptor induced PIP 2 depletion also causes inhibition of I KACh , resulting in desensitization. We confirmed the expression of G q -coupled muscarinic receptors in mouse atrial myocytes using reverse transcriptase-polymerase chain reaction. The involvement of M 1 and M 3 receptors in desensitization is examined using specific antagonists, 4-DAMP and pirenzepine, but they significantly reduced peak I KACh , implying nonspecific M 2 blockade. When ACh-induced phosphoinositide depletion was specifically inhibited using PLC␤1 knock-out mice, the extent of desensitization during 4 min was 47.5 ؎ 3.2%, which was not different from that in wild type (46.8 ؎ 2.1%). Phenylephrine-induced phosphoinositide hydrolysis and phenylephrine-induced inhibition of I KACh were not affected by PLC␤1 knock-out. To facilitate PIP 2 depletion, replenishment of PIP 2 was blocked by wortmannin. Wortmannin did not affect the desensitization and the recovery from desensitization. These results suggest that PIP 2 depletion by acetylcholine does not contribute to short-term desensitization of I KACh . The differential regulation of I KACh by different phospholipase C-linked receptors may imply that receptor co-localization is required for PIP 2 to act as a signaling molecule.
Phosphatidylinositol 4,5-bisphosphate (PIP 2 )
1 not only serves as a precursor of phospholipase C (PLC) to produce diacylglycerol and inositol trisphosphate, but it also exerts a direct role on the regulation of various cellular function. The underlying mechanism of PIP 2 action was investigated in detail for G protein-gated inwardly rectifying K ϩ (GIRK) channels, and it was shown that the activation of GIRK channels by G␤␥ depends on the presence of PIP 2 (1) (2) (3) (4) (5) . It has recently been reported that atrial GIRK currents evoked by acetylcholine via M 2 muscarinic receptors (I KACh ) are inhibited by the ␣ 1 -adrenergic receptors or by endothelin receptors by means of PIP 2 depletion (6, 7). These result suggest that PIP 2 depletion caused by PLC activation can function as a signaling mechanism in I KACh regulation. This mechanism is of particular interest because it provides a novel pathway by which crosstalk between different signaling pathways take place.
It is well known that the activation of I KACh is not sustained in the continuous presence of acetylcholine but undergoes desensitization. The mechanism of desensitization has been widely investigated, and it is understood as a complex process involving receptor phosphorylation, the nucleotide exchange and hydrolysis cycle of the G protein, and channel dephosphorylation (8 -12) . Because the role of PIP 2 on I KACh has been demonstrated, PIP 2 depletion via PLC-coupled muscarinic receptors has been proposed as a possible mechanism of I KACh desensitization (13, 14) . This hypothesis was supported by the finding that GIRK current expressed in COS-1 cells showed desensitization only when coexpressed with PLC-coupled muscarinic receptors. It was also shown that I KACh desensitization in rat neonatal myocytes was inhibited by 4-diphenylacetoxy-N-methypiperidine (4-DAMP) and U73122, which were used for inhibiting M 3 muscarinic receptors and PLC, respectively (14) . However, it is not yet clear whether intrinsic M 3 muscarinic receptors are involved in the desensitization of I KACh . The validity of the conclusion of their study appears to depend primarily on the specificity of the drugs, but recent studies indicate that action of 4-DAMP and U73122 may not be specific as originally thought (7, 15, 16) . Furthermore, the issue of the expression and function of PLC-coupled muscarinic receptors in cardiac myocytes are still controversial (7, 17) .
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EXPERIMENTAL PROCEDURES
Cell Isolation-Mouse atrial myocytes were isolated by perfusing Ca 2ϩ -free normal Tyrode solution containing collagenase (0.14 mg ml Ϫ1 , Yakult, Tokyo) on a Langendorff column at 37°C as described previously (16 Neomycin and wortmannin were from Biomol, 4-DAMP was from Tocris, and other chemicals were from Sigma. Drugs were prepared as concentrated stock solutions either in distilled water or dimethyl sulfoxide. All experiments were conducted at 35 Ϯ 1°C. When required, 10 M glibenclamide was applied in the presence of ACh to inhibit the ATP-sensitive K ϩ channel. To ensure a rapid solution turn-over, the rate of superfusion was kept above 5 ml min Ϫ1 , which corresponded to 50 times bath volume (100 l)/min.
Voltage Clamp Recording and Analysis-Membrane currents were recorded from single isolated myocytes in a perforated patch configuration using nystatin (ICN, 200 g/ml). Voltage clamp was performed using an Axopatch-1C amplifier (Axon Instruments). The patch pipettes were pulled from borosilicate capillaries (Harvard Apparatus) using a Narishige puller (PP-83, Tokyo). The patch pipettes used had a resistance of 2-3 megaohms when filled with the above pipette solutions. Electrical signals were displayed during experiments using an oscilloscope (Tektronix, TDS 210) and a chart recorder (Gould). Voltage clamp and data acquisitions were performed using a digital interface (Digidata 1200, Axon Instruments) coupled to an IBM-compatible computer at a sampling rate of 1-2 kHz, filtered at 5 kHz. Cells were voltageclamped at Ϫ40 mV, and the activation of I KACh by the application of ACh resulted in a shift in holding current level in outward direction. We have shown in our previous study (6) that during I KACh desensitization the current decrease occurs uniformly over the voltage range tested, and that the current change recorded at Ϫ40 mV well represents the change in I KACh . In the present study, we did not show the currentvoltage relationship, but it was checked in all experiments in the same way as described in the previous study (6) to confirm that the continuous current recording obtained at Ϫ40 mV represents I KACh .
RT-PCR-Total RNA was isolated from freshly isolated atrial myocytes using TRIzol reagent (Invitrogen). Total RNA yield and purity were analyzed spectrophotometrically (Beckman-Coulter, Fullerton, CA). RT-PCR was performed using a one-step RT-PCR kit (Invitrogen), which combines cDNA synthesis and PCR in a single reaction. 4 l of total RNA was added to a final reaction volume of 50 l consisting of 25 l of 2ϫ reaction mix (a buffer containing 0.4 mM of each dNTP and 2.4 mM MgSO 4 ), 0.2 M each of sense and antisense primer, 1 l of RT/ Platinum Taq mix. For the one-step RT-PCR, the reverse transcriptase step (50°C/30 min) was followed by an initial denaturation at 94°C/5 min followed by PCR amplification. The cycling profiles used were 30-s denaturing at 94°C, 1 min-annealing at 55°C, and 2-min extension at 72°C, for 40 cycles followed by a final extension step of 8 min at 72°C. The following primers were synthesized by Bionics: M 1 isoform, gctgtactggcgcatctacc (sense) and gcctgtgcctcaggatctac (antisense); M 2 isoform, ggatccctcagtctggtgac (sense) and ggtccgcttaactgggtagg (antisense); M 3 isoform, gacacctccagtgaccctct (sense) and ggtaggtgagtggcctggta (antisense); M 4 isoform, cagagctgtccaccacagag (sense) and gtagggtgtccaggtgagga (antisense); and M 5 isoform, ggtctccttcatcctctggg (sense) and gatctgagcagggtcctgtg (antisense). All primers were designed to avoid significant secondary and complementary structures and to have a GC content of 50 -60%. The gene-specific primer pairs were designed on the basis of cDNA sequences of mouse muscarinic receptors (GenBank TM accession numbers NM007698, AF264049, NM033269, NM007699, and AF264051), and unique oligonucleotide sequences were chosen from cDNA regions with minimal homology among different muscarinic receptors. The specificity of primer pairs was verified by searching the GenBank TM data base using BLAST and by amplifying the PCR products of the predicted size, visualized as a single discrete band by ethidium bromide staining on an agarose gel.
Animals-The PLC␤1 mutation (18) has been maintained in two different heterozygous genetic backgrounds, C57BL/6J and 129/sv. Heterozygous animals from the two backgrounds were mated to obtain homozygous mutant mice in the F1 background between C57BL/6J and 129/sv. The genotype of the progeny was determined by PCR as described previously (18) . Wild type littermates served as controls for the mutants. The mice had ad libitum access to food and water and were kept on a 14:10-h light-dark cycle with lights on at 6 a.m. Animals were housed and cared for according to the guidelines of the Korea Institute of Science and Technology for the care of experimental animals.
PI Hydrolysis in Atrial Tissues-The procedure described previously (18) was adapted for atrial tissues. Krebs buffer was composed of 118 mM NaCl, 4.7 mM KCl, 25 mM NaHCO 3 , 2.0 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , and 10 mM glucose (pH 7.4 at 37°C) gassed with 95% O 2 , 5% CO 2 , and chilled on ice for 10 min. The atria were isolated from sacrificed mice, placed in a dish containing oxygenated Krebs buffer kept on ice, blotted to remove excess blood, and rinsed with Krebs buffer. The atrial preparation was pre-labeled with myo- [2- 3 H]inositol (10 Ci/ml, Amersham Biosciences, TRK911) in 300 l of Krebs buffer saturated with 95% O 2 , 5% CO 2 for 1 h, treated with LiCl (10 mM) and myo-inositol (5 mM) for 20 min, and then incubated with an appropriate agonist for 40 min. The concentrations of agonists were chosen to induce maximum PI hydrolysis: 1 mM carbachol, 1 mM norepinephrine, and 300 nM endothelin-1. All procedures were performed in capped 5-ml flatbottomed tubes (Amicon) with periodical supplies of gas at 37°C. The reaction was stopped with 1 ml of CHCl 3 , CH 3 OH (1:2) and extracted with 0.6 ml of CHCl 3 , H 2 O (1:1). Total inositol polyphosphates in the aqueous phase were isolated on an AG1X-8 column and counted in a scintillation counter.
Statistics and Presentation of Data-Results in the text and the figures are presented as means Ϯ S.E. (n ϭ number of cells tested).
Statistical analyses were performed using the Student's t test. The difference between two groups was considered to be significant when p Ͻ 0.01 and not significant when p Ͼ 0.05.
RESULTS

Expression of Muscarinic Receptor Isoforms in Mouse Atrial
Myocytes-We first examined the presence of PLC-coupled muscarinic acetylcholine receptors (mAChR). It is known that odd-numbered muscarinic receptors (M 1 , M 3 , and M 5 ) stimulate PLC via G q/11 , whereas even-numbered muscarinic receptors (M 2 and M 4 ) stimulate effectors such as GIRK channels via G i/o protein (19) . Pharmacological identification of the subtypes suffers from the limitation in selectivity of ligands presently available (7). Molecular techniques allow more sensitive identifications, and in human atrial cells, transcripts of all five subtypes have been detected by RT-PCR, a finding that was confirmed by Western blot and immunocytochemistry (17) . On the other hand, Meyer et al. (7) reported that M 3 AChR transcripts were not detected by RT-PCR in rat atrial myocytes. Corresponding data are not available for mouse atrial myocytes. In Fig. 1 4, 6, 8, and 10) . The identities of all PCR fragments were confirmed by sequencing.
Effects of Specific Antagonists for PLC-linked Muscarinic
Receptors-To investigate whether ACh-induced PIP 2 hydrolysis leads to I KACh desensitization, we examined the effect on the I KACh desensitization of the substance known as specific antagonists for PLC-linked muscarinic receptors. I KACh was activated by applying 10 M ACh and recorded using a perforated patch clamp configuration (Fig. 2) . When the membrane potential was held at Ϫ40 mV, the application of 10 M ACh induced a rapid activation of outward currents followed by a decrease in currents due to desensitization. After a 6-min wash-out, the second application of ACh induced a current with the same amplitude, indicating full recovery from desensitization (Fig.  2a) . These characteristics are typical for I KACh as reported previously (6, 20, 21) . We also confirmed, by applying voltage ramps between ϩ60 and Ϫ120 mV, that the current-voltage relationship and the reversal potential were typical for I KACh (data not shown).
The hypothesis that desensitization in atrial cells is mediated by M 3 receptors is based in part on the observation that the desensitization was largely abolished by 0.5 M 4-DAMP, an M 3 receptor antagonist (14) . However, the results of subsequent studies have suggested that the abolishment of desensitization by 4-DAMP is not caused by the selective inhibition of desensitization but by the inhibition of fast activation caused by nonspecific antagonistic action of 4-DAMP on M 2 receptor (7, 15) . To test whether 4-DAMP can be used in mouse atrial myocytes for the purpose of selective inhibition of the M 3 receptor without affecting I KACh activation mediated by the M 2 receptor, we compared I KACh profiles in control and in the presence of the drug from the same cell. When 0.05 M 4-DAMP was pretreated before the second application of ACh, the amplitude of peak I KACh was significantly reduced, and the fast phase of desensitization was almost abolished (Fig. 2b) . When the current trace was seen in the expanded time scale, a significant slowing of the activation rate was recognized (Fig. 2d) . When the concentration of 4-DAMP was increased to 0.5 M, the inhibition of I KACh became more significant, and both the peak and steady state currents were reduced. M 1 antagonist pirenzepine was also tested. As shown in Fig. 2c , this compound at 1 M caused a reversible reduction of peak current as well as a loss of desensitization. Again, this was accompanied by slowing of the activation rate (Fig. 2e) . These results indicate that both 4-DAMP and pirenzepine affect the activation phase in such a way that the initial fast phase of the desensitization is masked, and thus they are not suitable as pharmacological probes to investigate the role of M 1 and M 3 receptors in the desensitization phase.
Acetylcholine-induced PI Hydrolysis and I KACh Desensitization in PLC␤1 Knock-out Mice-Because selective inhibition of PLC-coupled receptor using pharmacological probes failed, we next tried the knock-out mouse model. It was reported that muscarinic receptor-mediated PI hydrolysis in brain is selectively inhibited in PLC␤1Ϫ/Ϫ mice (18) . In Fig. 3 , we measured agonist-stimulated PI hydrolysis in mouse atrial myocytes isolated from wild type and PLC␤1Ϫ/Ϫ mice. PI hydrolysis was increased by carbachol as well as by norepinephrine and endothelin-1. Carbachol-induced increase in PI hydrolysis was markedly decreased (by 44.19%) in PLC␤1Ϫ/Ϫ mice. In contrast, norepinephrine or endothelin-1-induced PI hydrolysis increase did not change in PLC␤1Ϫ/Ϫ mice. These results indicate that in mouse atrial cells acetylcholine induces PI hydrolysis, and that about half of this activity is linked to PLC␤1. If I KACh desensitization in atrial myocytes is mediated by the activation of PLC through G q -coupled muscarinic receptors, it would be expected that in PLC␤1Ϫ/Ϫ mice desensitization is largely attenuated. To test this hypothesis, we compared the desensitization of I KACh in atrial myocytes of PLC␤1Ϫ/Ϫ mice and that of wild type mice.
In atrial myocytes isolated from PLC␤1Ϫ/Ϫ mice, ACh-induced desensitization was not significantly different from that of the wild type (Fig. 4, a and b) . I KACh was recorded using the same protocol as described in the legend for Fig. 2 . The results are summarized in Fig. 4c . When the extent of desensitization was determined to be the proportion of current decrease observed over a 4-min time span, it was found to be 46.8 Ϯ 2.1% (n ϭ 9) in wild type and 47.5 Ϯ 3.2% (n ϭ 7) in PLC␤1Ϫ/Ϫ mice. The amplitude of I KACh at peak activation measured at Ϫ40 mV was 954.4 Ϯ 103.8 pA (n ϭ 9) in the wild type and 824.8 Ϯ 128.3 pA (n ϭ 7) in PLC␤1Ϫ/Ϫ mice. After the second exposure to ACh, the peak amplitude of I KACh recovered almost completely both in wild type and in PLC␤1Ϫ/Ϫ mice. The ratio of the amplitudes of the second to the first peak current (I peak2 /I peak1 ) was 95.4 Ϯ 4.7% in wild type and 97.2 Ϯ 5.6% in PLC␤1Ϫ/Ϫ mice.
For comparison, the effect of ␣ 1 -adrenergic agonist phenylephrine (PE) on I KACh was also tested in PLC␤1Ϫ/Ϫ mice. When PE was applied together with the second exposure of ACh, desensitization of I KACh was significantly accelerated compared with that without PE (Fig. 4b) . The magnitude of the PE effect in PLC␤1Ϫ/Ϫ mice was not significantly different from that in wild type mice (Fig. 4, a and c) .
Considering that the inhibition of I KACh by PE is caused by PIP 2 depletion (6), this result is comparable with PI hydrolysis data shown in Fig. 3 , in which PI hydrolysis induced by PE was unchanged in PLC␤1Ϫ/Ϫ mice. Taken together, it is suggested that agonist-induced PIP 2 depletion is not always parallel to reduction of I KACh , in that PIP 2 depletion caused by muscarinic receptor activation does not cause inhibition of I KACh , whereas that by PE does inhibit I KACh .
Effects of PLC Inhibitor and PI Kinase Inhibitor on I KACh Desensitization-As shown in Fig. 3 , ACh-induced PI hydrolysis was not completely inhibited by PLC␤1 knock-out. In Fig.  5a , we tested the effect of neomycin, an inhibitor of phosphatidylinositol-specific phospholipase C, on the ACh-induced desensitization of I KACh . When 500 M neomycin was applied with ACh at the second exposure, the activation and desensitization of I KACh were not significantly affected. The extent of desensitization in the presence of neomycin was 48.6 Ϯ 3.7% (n ϭ 7). This value is not significantly different from that in control (44.2 Ϯ 2.3%, n ϭ 12). This result is consistent with the lack of a PLC␤1 knock-out effect, which suggests that in mouse atrial cells ACh-induced activation of the PLC-linked signaling pathway does not regulate GIRK channels.
The depletion of PIP 2 by the receptor-mediated activation of PLC can be potentiated by PI-4 kinase inhibitor, because the replenishment of PIP 2 after depletion is dependent on PI-4 kinase (22) . Wortmannin (WMN) is a known inhibitor of PI-3 kinase and PI-4 kinase. We previously showed that in the presence of WMN, the inhibition of I KACh by ␣ 1 -adrenergic activation is markedly potentiated, and its recovery was completely blocked (6) . Fig. 5b was used to determine whether the inhibition of PIP 2 replenishment by WMN affects the desensitization and recovery of I KACh . When the same series of experiments shown in Fig. 2a was performed in the presence of 100 M WMN, no significant differences were observed in the activation and desensitization of I KACh compared with the control. The extent of desensitization after 4 min was 44.2 Ϯ 2.3% in the control group and 45.8 Ϯ 4.0% in the WMN group (Fig. 5c) . Furthermore, WMN did not block the recovery of I KACh . In the presence of WMN, the peak amplitude of I KACh during the second exposure to ACh (I peak2 ) was larger than the current amplitude after desensitization, suggesting that recovery from desensitization still occurred in the presence of WMN. This result contrasted sharply with our previous result, which showed that recovery was completely blocked when WMN was treated with ␣ 1 -adrenergic agonist (6) . However, the recovery in Fig. 5c was not complete, and the I peak2 /I peak1 ratio was 70.9 Ϯ 9.1% (Fig. 5c) . Considering that the magnitude of the reduction of basal PIP 2 levels in unstimulated cells by WMN in this period of time (10 min) was about 75% (22) , it would appear that incomplete recovery of ACh-induced desensitization may be explained by the basal reduction of the PIP 2 level by WMN. These results suggest that in mouse atrial cells, PIP 2 depletion induced by ACh does not result in a reduction of I KACh .
DISCUSSION
The main question addressed in the present study is whether ACh induced PIP 2 hydrolysis causes inhibition of I KACh , resulting in current desensitization. The results obtained can be summarized as follows. 1) The expression of G q -coupled muscarinic receptors in mouse atrial myocytes was confirmed using RT-PCR. 2) Despite the fact that acetylcholine-induced phosphoinositide hydrolysis was specifically inhibited by 44.19% using PLC␤1 knock-out mice, the extent of desensitization in PLC␤1Ϫ/Ϫ was not different from that in wild type.
3) The activation of a 1 -adrenergic receptor caused inhibition of I KACh in PLC␤1 knock-out mice to the same extent as that in wild type mice. 4) When wortmannin was applied together with ACh to facilitate PIP 2 depletion, desensitization and the recovery from desensitization were not affected. From these results it was suggested that mouse atrial GIRK channels are not regulated by muscarinic receptor-mediated PIP 2 depletion.
The question raised by the present study in relation to the previous study (6) is why PI hydrolysis (PIP 2 depletion) by PLC-coupled muscarinic receptor activation does not regulate GIRK channels, whereas PIP 2 depletion by ␣ 1 -adrenergic receptor does. Considering that both receptors induce similar amount of PI hydrolysis (Fig. 3) and thus are expected to cause similar amount of PIP 2 depletion, this question is most intriguing. Possible explanations can be given by assuming two conditions: 1) the effect of PIP 2 depletion triggered by a specific receptor is limited to a local microdomain, and 2) GIRK channels are preferentially co-localized with ␣ 1 adrenergic receptor but not with M 1 (or M 3 /M 5 ) muscarinic receptors in mouse atrial myocytes. Given these conditions, PIP 2 can act as a localized signal regulated by a specific receptor in the regulation of GIRK channels. Direct experiments to prove the first assumption have not yet been performed in cardiac myocytes, but a line of evidence suggests that degradation and accumulation of PIP 2 are confined to a microdomain, enabling PIP 2 to act as a localized signal (23) (24) (25) . The second assumption is also supported by studies that investigated the mechanism of subtype-specific interaction of ␤-adrenergic receptors with the M 2 muscarinic receptor (26) . It is well known that the ␤ 1 adrenergic receptor-cAMP pathway shows a high degree of sensitivity to inhibitory modulation by M 2 muscarinic receptors, whereas ␤ 2 adrenergic receptor stimulation of cAMP accumulation is not susceptible to inhibitory modulation by M 2 muscarinic receptors. The molecular mechanism contributing specificity is suggested to be that M 2 muscarinic receptors are preferentially co-localized with ␤ 1 adrenergic receptor, but not with ␤ 2 adrenergic receptor (27) . The results of the present study, together with those of a previous study (6) , also imply that the differential topographical arrangement of GIRK channels with respect to the PLC-linked receptor is involved in channel regulation via PIP 2 .
It is worth noting that the result of the present study is not consistent with the results of previous studies performed in expression systems. When an M 1 (14, 28, 29) or M 3 receptor (29) was coexpressed with GIRK channels, channel activity was inhibited by muscarinic receptor agonists. These results indicate that unlike in native cells, GIRK channels can interact with either the M 1 or the M 3 receptor when they are co-expressed. This discrepancy implies that there exists a special mechanism in native cells that results in a specific topological arrangement of receptors, and this mechanism is disrupted when receptors are artificially over-expressed. Such a possibility was suggested by Wellner-Kienitz et al. (30) , who showed that the transient transfection of the ␤-adrenergic receptor in atrial myocytes results in isoproterenol-activated pertussis toxin-insensitive GIRK current, whereas in native cells ␤-adrenergic stimulation did not induce GIRK current. It is thus implied that experiments in native cells are required in studies investigating the specificity of signaling mechanisms and cross-talk between different signal pathways.
The conclusion of the present study that PIP 2 depletion is not related to desensitization of I KACh appears to be contradictory to that of Kobrinsky et al. (14) . However, if we look carefully, the experimental results are not contradictory to each other. Both studies showed that the ratio of I KACh at steady state (I ss ) after several minutes of desensitization to I KACh at peak (I peak ), I ss /I peak , was significantly greater in the presence of the M 3 receptor antagonist 4-DAMP. Kobrinsky et al. (14) considered this result as evidence for the contribution of M 3 receptor to the mechanism of desensitization. However, it is important to realize that I ss /I peak can be an index for the change in desensitization only when I peak is unchanged. It is well known that fast desensitization of I KACh is dependent on the amplitude and activation kinetics of I KACh (10, 20, 31) and that it is abolished under various experimental conditions where I peak is reduced by M 2 blockade or in the presence of low density of available receptor. Kobrinsky et al. (14) failed to recognize the effect of 4-DAMP on I peak , because they only monitored the change in I ss /I peak without monitoring the change in I peak from the same cell. In the present study, we have demonstrated that the inhibition of desensitization (increase in I ss /I peak ) by 4-DAMP occurred in parallel with a slowing of current activation and the inhibition of I peak (Fig. 2, b and d) . A similar result was also reported in recent studies performed in rat atrial myocytes (7, 15) . These results may suggest that the increase in I ss /I peak by 4-DAMP is due for the most part to the slowing of activation and the reduction of peak current, although the effect of 4-DAMP on the desensitization phase is not entirely excluded.
Kobrinsky et al. (14) showed that there is an increase in I ss /I peak in the presence of U73122, one of the most widely used PLC inhibitors. This result is not consistent with our experiments reported previously (16) , in that U73122 directly inhibits I KACh . We showed that the ED 50 of U73122 for I KACh blockade is 0.12 M, but Kobrinsky et al. (14) recorded I KACh in the presence of 1 M. Meyer et al. (7) also observed the inhibition of I KACh by U73122. We do not know the reason for the discrepancy among different studies, but differences in experimental conditions may possibly to be involved. Kobrinsky et al. (14) and Meyer et al. (7) used whole cell recording, whereas we used the nystatin-perforated patch experiment. Kobrinsky et al. (14) used cultured myocytes from newborn rats, whereas we and Meyer et al. (7) used adult myocytes from mice and rats, respectively. So, the possibility that differences in preparation of atrial myocytes caused the discrepancy may need to be considered. The previous report showing that inositol phosphate content and sensitivity to U73122 in cardiomyocytes are altered by the cell isolation procedure and vary depending on time in culture (32) may support this possibility.
In the present study, we only showed that PIP 2 depletion is not related to I KACh desensitization, without pursuing what the mechanism of desensitization is. It is known that the shortterm desensitization is made up of several components with different kinetics of onset and recovery. Among them, slow components seem to represent receptor desensitization, presumably mediated by phosphorylation via receptor kinase(s) and subsequent events such as receptor internalization (8, 9) . In contrast to the slow component, a fast phase of desensitization, developing with a time constant in the range of seconds, is localized downstream of the activating receptor. Several mechanisms have been proposed for fast desensitization. Shui et al. (11) suggested channel dephosphorylation as the underlying mechanism, whereas Hong et al. (12) reported the contribution of an unidentified cytosolic protein. The major properties of fast desensitization, such as the rate of current decay and its membrane-delimited nature, can be accounted for by a model relating fast desensitization, analogous to activation, to the nucleotide exchange and hydrolysis cycle of the G protein (10) . However, the above-mentioned mechanisms do not describe all of the properties of I KACh in a native myocyte. Therefore further experimental work will be required to clarify the mechanism of desensitization.
